Business / Finance

RSS

AMAG fourth quarter total revenues increase to $17.2 million

AMAG Pharmaceuticals, Inc. a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2010.

25 Feb 2011

Savient launches KRYSTEXXA in the U.S.

Savient Pharmaceuticals, Inc. announced the official full U.S. commercial launch of KRYSTEXXA™ (pegloticase), which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of chronic gout in adult patients refractory to conventional therapy. KRYSTEXXA is now the first and only therapy available to address this unmet medical need.

25 Feb 2011

Tenet fourth quarter adjusted EBITDA increases 28.9% to $281 million

Tenet Healthcare Corporation today reported adjusted EBITDA of $281 million for the fourth quarter ended December 31, 2010, an increase of $63 million, or 28.9 percent, compared to $218 million for the fourth quarter of 2009. Net income attributable to common shareholders for the fourth quarter of 2010 was $74 million, or $0.14 per diluted share, compared to $21 million, or $0.04 per diluted share, for the fourth quarter of 2009.

25 Feb 2011

Harvard Bioscience fourth quarter revenues increase 6.8% to $1.9 million

Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today reported unaudited financial highlights for the fourth quarter and full year ended December 31, 2010.

From Harvard Bioscience 25 Feb 2011

Golden Meditech to acquire remaining shares in Chinese herbal medicine business for HK$90 million

Golden Meditech Holdings Limited, China's leading integrated healthcare enterprise, is pleased to announce that the Group will acquire the remaining interests in the Group's Chinese herbal medicine business for a total consideration of HK$90 million in shares.

25 Feb 2011

Western Digital establishes new HDD research and development center in Singapore

Western Digital announced today that it has established a research and development center in Singapore, where the company will leverage the local talent pool and expertise of research organizations, such as Singapore's A*STAR Data Storage Institute, and universities in the development of advanced hard drive technologies.

25 Feb 2011

LinkMed reports fourth quarter net sales of SEK 20.0 million

LinkMed AB: Net sales for the year were SEK 80.5 million. Currency effects had a negative impact on sales of SEK 8 million for the year.

25 Feb 2011

Sanofi-aventis completes acquisition of BMP Sunstone

Sanofi-aventis today announced that it has completed the previously announced acquisition of BMP Sunstone Corporation.

25 Feb 2011

Thermo Fisher to sell Athena Diagnostics and Lancaster Labs businesses for $940 million

Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has signed definitive agreements to sell its Athena Diagnostics and Lancaster Laboratories businesses for a total of $940 million in cash.

From Thermo Fisher Scientific Inc. 24 Feb 2011

Bruker to acquire Michrom Bioresources

Bruker today announced that it has signed an agreement to acquire Michrom Bioresources, Inc., a 20 year old, privately owned company based in Auburn, California. Michrom provides liquid chromatography instrumentation, accessories, and consumables for applications in the life science, chemical and applied markets.

24 Feb 2011

Integra LifeSciences fourth quarter revenues increase 6% to $10.6 million

Integra LifeSciences Holdings Corporation today reported its financial results for the fourth quarter and full year ending December 31, 2010. Total revenues for the fourth quarter were $194.1 million, reflecting an increase of $10.6 million, or 6%, over the fourth quarter of 2009.

24 Feb 2011

BRI and Eureka Genomics form strategic alliance to advance cancer treatments

Baylor Research Institute (BRI), the research arm of Baylor Health Care System, and bioinformatics pioneer Eureka Genomics (EG) have formed a strategic alliance to achieve a better understanding of the causes of colorectal cancer, potentially leading to advancements in the disease's prevention, management and treatment.

24 Feb 2011

ImmunoCellular to receive gross proceeds of $8.1M from sale of 5.2M units

ImmunoCellular Therapeutics, Ltd., announced it has entered into securities purchase agreements with certain institutional and other investors in connection with a private placement financing.

24 Feb 2011

CollaborativeCARE Conference, HIMSS form alliance to lead healthcare information technology

CollaborativeCARE Conference (C3), the first healthcare conference designed to foster regional coordinated care by educating specialists, primary care physicians and patients, today announced an alliance with HIMSS that will provide customized access to health information technology at the inaugural C3 event in Long Beach, Calif., scheduled for Nov. 15-20, 2011.

24 Feb 2011

EpiCept 2010 fourth quarter net loss is $0.06 per share

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2010, and provided an update on its key business initiatives.

24 Feb 2011

Western Pistachio Association partners with USDA's MyPyramid

Western Pistachio Association (WPA) today announced its official partnership with USDA's MyPyramid, ramping up the WPA's nutrition educational programs to coincide with the announcement of the new 2010 Dietary Guidelines for Americans (DGA). The announcement was made at the WPA Annual Conference in Santa Barbara before more than 500 attendees, the majority of whom are growers in the American pistachio industry.

24 Feb 2011

Xenogenics retains Emmes to assist with development, execution of its capital formation strategy

Xenogenics Corporation, a majority owned subsidiary of MultiCell Technologies, Inc., is pleased to announce it has retained the Emmes Group to assist with the development and execution of its capital formation strategy to help finance expanded human clinical trials of its Ideal BioStent.

24 Feb 2011

Pharmagesic to acquire WEX shares

Pharmagesic Inc. announced today that the offer by its wholly-owned subsidiary, 7735308 Canada Limited to acquire all of the outstanding restricted voting shares of WEX Pharmaceuticals Inc. not already owned by Pharmagesic for C$0.14 cash per WEX Share has been extended to 5:00 p.m. on March 10, 2011.

23 Feb 2011

GTCR to acquire Sterigenics International

GTCR, a leading private equity firm, today announced it has signed a definitive agreement with Silverfleet Capital and PPM America Capital Partners to acquire Sterigenics International, the leading global provider of contract sterilization and ionization services for medical devices, food products, and advanced applications.

23 Feb 2011

Intercell places EUR 33.0m of Senior Unsecured Convertible Notes in private placement transaction

Intercell AG today announced that it successfully placed EUR 33.0m of Senior Unsecured Convertible Notes in a private placement transaction, which was increased due to investor demand.

23 Feb 2011